首页|NLRP3炎症小体在认知功能障碍相关疾病防治中的作用及中药干预研究进展

NLRP3炎症小体在认知功能障碍相关疾病防治中的作用及中药干预研究进展

扫码查看
阿尔茨海默病(Alzheimer's disease,AD)、血管性痴呆(vascular dementia,VD)及创伤性脑损伤(traumatic brain injury,TBI)作为认知功能障碍疾病中较常见的疾病,具有高致残率、高致死率的特点,给个体家庭带来了沉重的负担。AD、VD、TBI虽具体发病机制不同,但其发病均与核苷酸结合寡聚化结构域样受体蛋白3(nucleotide-binding oligomerization domain-like re-ceptor protein 3,NLRP3)息息相关。NLRP3炎症小体通过参与神经炎症反应、介导小胶质细胞极化、调控减少β淀粉样蛋白(amyloid β-protein,Aβ)沉积、神经纤维缠结(neurofibrillary tangles,NFTs)形成、调控细胞自噬、维持大脑内稳态、维持突触稳态等方式,参与AD、VD、TBI发生发展。同时既往研究证实,中药可通过干预NLRP3炎症小体发挥减轻神经炎症、促进小胶质细胞向M2极化、减少Aβ沉积和NFTs形成、调控细胞自噬、维持大脑内稳态的作用,起到防治认知功能障碍相关疾病的同时减轻患者心理及经济压力、提高患者生活质量的作用。故该文拟通过阐述NLRP3炎症小体在AD、VD、TBI中的作用,详细总结中药干预NLRP3炎症小体防治AD、VD、TBI的最新研究成果,以期传承中医药精华,为中医药临床防治认知功能障碍相关疾病提供参考和依据,同时为后续中医药防治认知功能障碍相关疾病的深入研究提供思路和方向。
Role of NLRP3 inflammasome in prevention and treatment of cognitive impairment-related diseases and traditional Chinese medicine intervention:a review
Alzheimer's disease(AD),vascular dementia(VD),and traumatic brain injury(TBI)are more common cognitive im-pairment diseases characterized by high disability and mortality rates,imposing a heavy burden on individuals and their families.Al-though AD,VD,and TBI have different specific mechanisms,their pathogenesis is closely related to the nucleotide-binding oligome-rization domain-like receptor protein 3(NLRP3).The NLRP3 inflammasome is involved in neuroinflammatory responses,mediating microglial polarization,regulating the reduction of amyloid β-protein(Aβ)deposition,neurofibrillary tangles(NFTs)formation,auto-phagy regulation,and maintaining brain homeostasis,and synaptic stability,thereby contributing to the development of AD,VD,and TBI.Previous studies have shown that traditional Chinese medicine(TCM)can alleviate neuroinflammation,promote microglial polari-zation towards the M2 phenotype,reduce Aβ deposition and NFTs formation,regulate autophagy,and maintain brain homeostasis by intervening in NLRP3 inflammasome,hence exerting a role in preventing and treating cognitive impairment-related diseases,reducing psychological and economic pressure on patients,and improving their quality of life.Therefore,this article elucidated the role of NL-RP3 inflammasome in AD,VS,and TBI,and provided a detailed summary of the latest research results on TCM intervention in NLRP3 inflammasome for the prevention and treatment of these diseases,aiming to inherit the essence of TCM and provide references and foun-dations for clinical prevention and treatment of cognitive impairment-related diseases with TCM.Meanwhile,this also offers insights and directions for further research in TCM for the prevention and treatment of cognitive impairment-related diseases.

NLRP3 inflammasomeAlzheimer's diseasevascular dementiatraumatic brain injurycognitive impairmenttradi-tional Chinese medicine(TCM)

王彩红、魏晓涛、赵永强、王东红、薛建军、宋子晴、汤峰、刘荣鑫、王春爱

展开 >

甘肃中医药大学第一临床医学院,甘肃兰州 730000

甘肃省中医院泌尿外科,甘肃兰州 730000

甘肃省中医院麻醉科,甘肃兰州 730000

甘肃省中西医结合麻醉临床研究中心,甘肃兰州 730000

甘肃省中医药研究院中西医结合麻醉与循证医学研究所,甘肃 兰州 730000

展开 >

NLRP3炎症小体 阿尔茨海默病 血管性痴呆 创伤性脑损伤 认知功能障碍 中医药(TCM)

甘肃省科技计划-临床医学研究中心建设项目甘肃省重点研发计划甘肃省重点研发计划兰州市科技计划

20JR10RA43522YF7FA10120YF8FA0882023-2-18

2024

中国中药杂志
中国药学会

中国中药杂志

CSTPCD北大核心
影响因子:1.718
ISSN:1001-5302
年,卷(期):2024.49(4)
  • 75